Debt (Details) - USD ($) $ in Thousands		1 Months Ended								3 Months Ended		9 Months Ended
	May 06, 2020	Sep. 30, 2021	Aug. 31, 2021	Jul. 31, 2021	Jun. 30, 2021	Apr. 30, 2021	Feb. 28, 2021	Feb. 22, 2021	Feb. 17, 2021	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Apr. 01, 2021	Mar. 31, 2021
Debt Disclosure [Abstract]
Advance accounts receivable						$ 49		$ 30	$ 30			$ 64
Accrued advances unpaid						$ 6		$ 4				$ 4
Accounts receivable advances repaid															$ 20
Advance fee														$ 1	1
Accounts receivable advances in cash															$ 25
Advance fee, percentage		5.00%	5.00%							5.00%		5.00%			5.00%
Received cash from affiliates		$ 36,000	$ 50,000	$ 10,000
Account receivable description				The company accrued a 5% advance fee and recorded $500 as interest expense during the three months ended September 30, 2021. Upon collection of the accounts receivable the Company will repay the advance plus the 5% fee.
Interest expense										$ 4
Advance fees												5.00%
Notes payable, description	the Company received loan proceeds in the amount of approximately $123 under the Paycheck Protection Program (“PPP”). The PPP, established as part of the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”), provides for loans to qualifying businesses for amounts up to 2.5 times of the average monthly payroll expenses of the qualifying business. The Company may apply for the loans and accrued interest forgiven after a period of either eight or twenty-four weeks, as long as the borrower uses the loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and maintains its payroll levels. The amount of loan forgiveness will be reduced if the borrower terminates employees or reduces salaries during the period in question. Under the terms of the related promissory note, the unforgiven portion of the PPP loan is payable over two years at an interest rate of 1%, with a deferral of payments for the first six months.						the Company issued an aggregate of $75 in unsecured notes, $30 to related parties and $45 to other investors. The Company received $15 in cash and $15 in exchange for an account receivable advance, received in the prior year, from related parties, and $45 in cash from other investors. The unsecured notes are convertible by the holder into common stock at any time at a price per share of $0.50. Upon closing a new financing of at least $1,000 in aggregate proceeds, the Company can force conversion at a price equal to the lesser of $0.50 per share or the price per share of the new financing. The notes bear interest at the rate of 10% per annum and are due December 31, 2021.
Other income												$ 125
Accrued unpaid percentage						5.00%						5.00%
First installment					$ 40
Accrued interest expense					$ 5					$ 84	$ 83		$ 221
Interest rate percentage		4.00%								4.00%		4.00%
Cash received from investor		$ 75								$ 75		$ 75
Interest rate		20.00%								20.00%		20.00%
Accrued interest expense												$ 243
Interest expense										$ 75	73	211	194
Convertible promissory notes										35	28	97	76
Outstanding to related parties										$ 40	$ 45	$ 114	$ 118